From start-ups to leading global companies, Greater Fort Lauderdale provides a stimulating and supportive business environment for success in the life sciences.


Despite deaths and trial halts, Leerink sees Juno positives

After FDA rejection, Novartis pulls Amgen biosim candidate from EMA

Novartis lays out catch-up plan in immuno-oncology fueled by new-gen treatments

Novartis, Pfizer join with Big Biopharma peers to create tech standards that streamline how HCPs access info